Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
Conditions
- Advanced Lung Adenocarcinoma
Interventions
- DRUG: bemcentinib
- DRUG: pacritinib
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators